Cencora PharmaLex provides pharmaceutical and healthcare consulting services, focusing on regulatory affairs, product development, and quality management.

Cencora PharmaLex

PharmaLex is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives around the world

PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.

Learn more at http://www.pharmalex.com

PharmaLex

Unlock the future of personalized medicine with insights from Dr. Christian K Schneider in his latest article on targeted therapies!

Key takeaways include:
✅ The revolutionary impact of targeted medicines on patient outcomes.
✅  How biomarkers and companion diagnostics (CDx) connect life-saving therapies 
✅  The critical role of AI and machine learning in advancing precision medicine.
✅  Navigating regulatory pathways for successful approval and delivery.
✅  The importance of collaboration between developers, diagnostic teams, and regulators.

Explore the full article here: https://lnkd.in/dQhNng8V

#PharmaLex #TargetedMedicine #TargetedTherapies #Biomarkers #CompanionDiagnostics #RegulatoryAffairs #PharmaceuticalInnovation

What an incredible session at #JSM2024 in Portland discussing the regulatory acceptability of Bayesian methods! 

A huge shoutout to our team members Martina Fortin, Lauren Frazee, PhD, Brad Carlin and our brilliant speakers John Scott and Freda Cooner from FDA , Amy Xia from Amgen, Lauren Frazee, PhD from PharmaLex, and Ruitao Lin from MD Anderson Cancer Center.

The future of Bayesian methods in US and international regulatory science is truly promising!

Learn more about Statistics & Data Science at PharmaLex here: https://lnkd.in/gxRQJ48n

#BayesianMethods #RegulatoryScience #PharmaLex #DataScience

Automation, AI, and data analytics are transforming pharmaceutical outsourcing, bringing unprecedented agility, efficiency, and cost-effectiveness. Curious about how these innovations are shaping the future of drug development and commercialization?

Learn more in our latest blog post from Kirsten Jacobs, PhD, Chief Strategy Officer with PharmaLex: https://lnkd.in/dS-Qs_gc 

#PharmaLex #FutureofHealthcare #AI #Innovation

Stay informed of all the latest news, events, and thought leadership in the pharmaceutical, biotech and medical device industry!

Subscribe to our newsletter for exclusive industry insights about the rapidly-evolving #pharmaceutical industry ➡️ https://lnkd.in/ejiXKmbd

#Pharmalex #Newsletter

Join us tomorrow, August 6th, at 4:00 PM CET for our second Summer Shorts of our TMF Excellence Edition on the topic: "Risk-Based Quality Review: Inside Out". 

Our experts will guide you through managing and resolving conflicting directives. Learn how to navigate the complexities and find the right path for your organization.

⏰ Duration: 30 min

Secure your spot now: https://lnkd.in/dqTHKRmN

#PharmaLex #TMFExcellence #RiskBasedReview #ClinicalResearch #Webinar #SummerShorts Rob Jones

Happy to be at #JSM2024 in Portland with the other members of the Cencora-PharmaLex "dream team", Martina Fortin and Lauren Frazee, PhD! 

We're here for one more day; if you're in Portland, please stop by Booth 310 in the convention center Expo, say hello, and pick up some cool swag!

McKesson Corporation

Cardinal Health

AmerisourceBergen

IQVIA Holdings, Inc.

Cencora PharmaLex faces strong competition in the pharmaceutical services and consulting market. Its main competitors include large pharmaceutical distributors like McKesson, Cardinal Health, and AmerisourceBergen, which offer similar services and have significant market presence. Additionally, specialized healthcare consulting and analytics firms like IQVIA pose competition in the consulting and regulatory affairs segments. These competitors have substantial financial resources, established client relationships, and global reach, making the market highly competitive. Cencora PharmaLex will need to leverage its expertise in regulatory affairs and consulting services, as well as its recent acquisition by AmerisourceBergen, to maintain and grow its market position.

IQVIA Holdings

Noerr

Not specified

Align Technology, Inc.

Medpace

Establishes a regulatory framework for laboratory-developed tests (LDTs), modifying the definition of in vitro diagnostic products (IVDs) to include LDTs.

Proposed changes to marketing exclusivity periods and regulatory processes in the EU.

Domain Not Resolving

HSTS

Google Maps

Amazon

Mobile Non Scaleable Content

Person Schema

AJAX Libraries API

Amazon Virginia Region

PostalAddress Schema

Microsoft

Executive Vice President; Development Consulting & Scientific Affairs

Carolyn Belcher

VP Human Resources

Claudia Hinrichs

Vice President of Finance and Operations

Jane Lin

Vice President, Development Consulting and Scientific Affairs

Mark Lane

EVP Pharmacovigilance

Raphael Troost

Sr. Director, Head of Regulatory Affairs US

Adair Turner

Marketing and Product

Alex Lin

HR Associate Director

Ana Rodrigues

Director, Head of Regulatory CMC Team (Mannheim)

Andrea Band

Associate Director Regulatory Affairs

Athena Chiladakis

Ann McGee

Associate Consultant

Terrance Thiel

Senior Director, Principal Consultant

Christopher Gauglitz

Chief Operating Officer

Thomas Dobmeyer

CEO and Managing Partner

Firat Gökcen

Associate Director Pharmacovigilance

Hessen Consulting Companies

Acquired Health Care Companies (Top 10K)

Pharmaceutical Companies With More Than $1M in Revenue (Top 10K)

Germany Acquired Companies With More Than $50M in Revenue

PharmaLex is a provider of specialized services for the pharma, biotech, and medtech industries.

The company guides its clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes, and post-approval / maintenance post-launch activities. PharmaLex's experts use technology-enabled solutions to support clients through the entire product lifecycle. The company delivers results — going above and beyond the standard to deliver tailor-made solutions worldwide.

The PharmaLex Group now has over 3000 employees, with 67 offices in 32 countries and more than 1000 satisfied clients worldwide.

Computer and Software Services and Scientific Services

Friedrichsdorf

Hessen

Germany

Europe

AmerisourceBergen Expands Global Footprint and Commercialization Solutions with Acquisition of PharmaLex

PharmaLex seals merger with UK’s NeoHealthHub

AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex

PharmaLex expands pricing & reimbursement and health economics platform with EBMA Consulting merger

PharmaLex expands global footprint capabilities for clinical and regulatory services with Phlexglobal merger

The merger with Oblikue Consulting gives PharmaLex deeper pricing and reimbursement expertise and strengthens footprint in Spain

news impact assignment basic	general	Aug 13, 2024 4:34 PM	da2ed08b
public peers	general	Aug 13, 2024 4:34 PM	24eb91e8
news daily refresh	general	Aug 13, 2024 4:34 PM	0ca33ce0
news processing daily refresh	general	Aug 13, 2024 4:34 PM	e90c892f
news impact assignment daily	general	Aug 13, 2024 4:34 PM	cc62509e
news processing basic	general	Aug 13, 2024 4:34 PM	a1fb1f87
company summary	general	Aug 13, 2024 4:34 PM	c767e664
signals	general	Aug 13, 2024 4:34 PM	ce0d0d95
crunchbase trigger	general	Oct 28, 2024 1:50 PM	45a07b16
crunchbase profile	general	Oct 28, 2024 3:44 PM	195afd0c
li profile	general	Aug 13, 2024 4:34 PM	afc99cea
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	bbdab280
peers	general	Aug 13, 2024 4:34 PM	24768224
news basic	general	Aug 13, 2024 4:34 PM	673d4ee6
bundesanzeiger	filings	Aug 13, 2024 4:34 PM	0c299ca8
financials download nd	financials
private financials	financials

COM:PHARMALEX

Cencora PharmaLex